Despite well-documented benefits, exercise interventions are often underutilized in the multiple myeloma population. This review provides evidence-based strategies for developing safe and effective exercise programs for these patients.
Join our experts for a discussion- and case-based webinar exploring the latest in NTRK fusion-positive non-small-cell lung cancer and equip yourself to best manage this subset of patients.
Recent trials have shown survival benefits of intensified regimens in EGFR-mutant NSCLC, but they come at the cost of increased toxicity and treatment burden. So which patients should receive up-front intensification?
The treatment strategy for liver metastases is predominantly determined by the primary cancer site, which made this patient with metastases from breast and colorectal cancer quite challenging to manage.
CAR T-cell therapy for central nervous system tumors in children and adults induces unique neurotoxicities. Learn about the underlying mechanisms, clinical implications, and management approaches.
Marking a major milestone in chronic myeloid leukemia treatment
Tyrosine kinase inhibitors have transformed the treatment of chronic myeloid leukemia, a condition that had limited therapeutic options before.
In this 25th year since the first phase 2 trials of the first TKI, we speak to a researcher and clinician who has been involved since the early days. Dr. Jorge Cortes shares his experience and talks about the impact of these drugs, not only in the treatment of CML but also more widely.
Are you up to date on targeted therapies for relapsed/refractory AML?
Join Prof. Amer Zeidan and his expert guests to hear about innovations in molecular testing, emerging therapies, and IDH-targeted treatments, and get practical advice for improving your patient care.
Supported by: independent educational grant from Rigel
Join Professor Joy Ho as she leads a panel of Asia-Pacific-based experts, discussing real-life patient cases and their experiences with CAR T-cell therapy for the treatment of R/R DLBCL or R/R FL. Learn about how to identify appropriate patients for CAR T-cell therapy and how to optimize outcomes with this treatment modality. Gain insights into essential aspects of pre- and post-infusion management, as well as important considerations for treatment sequencing.
This educational activity is not intended for healthcare professionals based in the UK, US, or off-label Asia-Pacific countries.
The treatment strategy for liver metastases is predominantly determined by the primary cancer site, which made this patient with metastases from breast and colorectal cancer quite challenging to manage.
Carfilzomib is mostly associated with gastrointestinal or cardiovascular side effects, but this patient with relapsed multiple myeloma developed pulmonary complications, which resolved once the drug was discontinued.
Bilateral IPE cysts in a 3-year-old triggered investigations that revealed acute lymphoblastic leukemia. Chemotherapy reduced the cysts, supporting a possible link between IPE cysts and hematologic malignancies.
Lung cancer continues to be a significant health burden in the United States, with 2025 estimates indicating approximately 226,650 new cases and 124,730 deaths. NSCLC is the predominant histological subtype of lung cancer, representing …
In this report, a panel of multiple myeloma experts assesses the role of melflufen (melphalan flufenamide) in the treatment of patients with relapsed or refractory multiple myeloma (RRMM). Based on available data, recommendations for …
A 74-year-old gentleman with a background of early stage melanoma presented with subacute onset of asymmetric sensorimotor symptoms, involving all four limbs. This had progressed over the preceding three-months - he had become severely debilitated …
Adnexal torsion and pedunculated subserosal leiomyoma torsion are significant gynecological emergencies requiring prompt recognition and surgical intervention. Although ultrasound remains the primary imaging modality, cross-sectional imaging with …
Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.
Professor Joy Ho and a panel of Asia-Pacific-based experts will examine real-life patient cases in this Masterclass, exchanging insights into their clinical experiences of using CAR T-cell therapy to treat patients with R/R DLBCL or R/R FL.
This educational activity is not intended for healthcare professionals based in the UK, US, or off-label Asia-Pacific countries.
This hub presents a curated selection of educational materials focused on the latest clinically relevant topics related to the use of chimeric antigen receptor (CAR) T‑cell therapy for the treatment of relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and R/R follicular lymphoma (FL).
This content has been developed in collaboration with and funded by the sponsor Novartis Pharma AG and is not intended for healthcare professionals based in the UK and US.
Hear directly from experts in acute myeloid leukemia about innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.
Vulvar cancer is a rare disease with an age standardized rate of about 0.9/100,000 women worldwide in 2020 (about 45,000 cases worldwide) [ 1 ]. Regions with the highest incidence rates are Western and Northern Europe, Northern America, Australia …
Patients with metastatic non-small cell lung cancer (NSCLC) harbouring targetable genomic alterations who progressed on standard tyrosine kinase inhibitors (TKIs) have limited treatment options, with platinum-based chemotherapy offering modest …
Colorectal cancer (CRC) is the third most common malignant tumor globally exhibiting a rising incidence rate-particularly among younger populations under 50, where rates increased annually in recent years [ 1 ]. According to the World Health …
This study aimed to investigate the clinical features of varicella-zoster virus (VZV) meningitis cases diagnosed by polymerase chain reaction (PCR) despite normal routine cerebrospinal fluid (CSF) testing. A retrospective review was performed on …
Despite well-documented benefits, exercise interventions are often underutilized in the multiple myeloma population. This review provides evidence-based strategies for developing safe and effective exercise programs for these patients.
Recent trials have shown survival benefits of intensified regimens in EGFR-mutant NSCLC, but they come at the cost of increased toxicity and treatment burden. So which patients should receive up-front intensification?
